Panel to review prices of drugs, medical devices

The government has constituted a panel to reform the pricing framework for drugs and medical devices. The committee will evaluate the availability and pricing of essential medicines, balance price and availability, and consider institutional reforms within the NPPA. It will also design a price moderation framework for medical devices and minimize imports.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MLSDmCr
via IFTTT